000 01588 a2200493 4500
005 20250518080726.0
264 0 _c20201005
008 202010s 0 0 eng d
022 _a1791-2423
024 7 _a10.3892/ijo.2020.4958
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFeng, Yan
245 0 0 _aPAX2 promotes epithelial ovarian cancer progression involving fatty acid metabolic reprogramming.
_h[electronic resource]
260 _bInternational journal of oncology
_c03 2020
300 _a697-708 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aCarcinoma, Ovarian Epithelial
_xgenetics
650 0 4 _aCell Line
650 0 4 _aCell Proliferation
650 0 4 _aCell Transformation, Neoplastic
650 0 4 _aDisease Progression
650 0 4 _aFatty Acids
_xmetabolism
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMice, SCID
650 0 4 _aMitochondria
_xmetabolism
650 0 4 _aOvarian Neoplasms
_xgenetics
650 0 4 _aOxidative Phosphorylation
650 0 4 _aPAX2 Transcription Factor
_xgenetics
650 0 4 _aPrognosis
650 0 4 _aProgression-Free Survival
700 1 _aTang, Yong
700 1 _aMao, Yannan
700 1 _aLiu, Yingzhao
700 1 _aYao, Desheng
700 1 _aYang, Linkai
700 1 _aGarson, Kenneth
700 1 _aVanderhyden, Barbara C
700 1 _aWang, Qi
773 0 _tInternational journal of oncology
_gvol. 56
_gno. 3
_gp. 697-708
856 4 0 _uhttps://doi.org/10.3892/ijo.2020.4958
_zAvailable from publisher's website
999 _c30503820
_d30503820